Efficacy and safety of UCB-derived or autologous CIK cells combined with interferon therapy in patients with chronic hepatitis B

ObjectiveTo investigate the efficacy and safety of umbilical cord blood (UCB)-derived or autologous cytokine-induced killer (CIK) cells combined with interferon therapy in patients with chronic hepatitis B (CHB). MethodsThirty CHB patients hospitalized in the Department of Infectious Diseases from O...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsman: LIU Bo
Materialtyp: Artigo
Språk:Chinês
Publicerad: Editorial Department of Journal of Clinical Hepatology 2014-09-01
Serie:Linchuang Gandanbing Zazhi
Ämnen:
hepatitis B
chronic; killer cells; interferon type Ⅱ
Länkar:http://www.lcgdbzz.org/qk_content.asp?id=6003&ClassID=86133151
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk